Download on the App Store

Android app coming soon

Want to know when it's ready? Get notified

100.ca · Thursday, November 19, 2026 · Saskatchewan

Saskatchewan to cover two drugs for advanced ovarian cancer

Starting Dec. 1, Saskatchewan's drug plan will cover two ovarian cancer medications, Keytruda and Elahere, for women who meet medical criteria, the province announced Tuesday. Coverage is limited to advanced or platinum-resistant cases, and patients must have completed one earlier systemic treatment and undergo cell-marker testing. The province expects only about eight to 10 women to qualify each year. The Saskatchewan Cancer Agency says the drugs can delay disease progression and sometimes help patients live longer. Ovarian Cancer Canada lobbied for the coverage. About 3,000 Canadian women will be diagnosed with ovarian cancer this year, the Canadian Cancer Society estimates.

100 wordsSource: CBC News, by Colleen Silverthorn

← The full briefing for this day · Subscribe by Email